Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
CPOs are facing added pressures as they navigate the people side of business transformation. This report by Criticaleye Partner LACE Partners looks at HR’s role in business transformation, the challenges CPOs face...
Martin Balaam, CEO of Pimberly and Jacqui Summons, NED/Fractional CHRO join Criticaleye's Senior Editor, Jacob Ambrose Willson to explore the demands of private equity ownership from driving value creation and manag...
When it comes to employee appreciation, the most successful organisations find ways to address a wide range of their employees’ needs. This report by Criticaleye Partner Reward Gateway | Edenred explores...
Displaying 1 to 3 of 401
 (002).png "Palo Alto Networks"){kind=logo}
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
